Clinical

Cardiotoxicity is damage to the heart muscle. Chemotherapy drugs that are used to treat blood cancer can cause damage to the heart tissue. This is especially true for anthracycline chemotherapy...

Digital therapeutics (DTx) first entered clinical discussions in the 1990s. The idea was that technology could improve healthcare access. It could help overcome barriers of location, time, and resources. This...

Essential thrombocythemia (ET) is a rare disease. People who have it, though, on average, tend to have a normal life expectancy. People who have ET have an increased number of...

There is growing evidence that spending time in nature can help people feel less depressed, anxious or stressed.1,2 Maintaining our connection to nature can improve one’s quality of life and...

Cancer development, treatment, and outcomes are tricky topics to understand. The underlying reasons why a person gets cancer or how they might respond to treatment are often unknown and depend...

Polycythemia vera (PV) is an uncommon slow-growing blood cancer in which bone marrow produces excess red blood cells. You can have it for years without having any symptoms. It is...

Editor’s Note: LGBTQ+ stands for people who identify as lesbian, gay, bisexual, transgender, or queer. To learn more about gender identity, check out the interactive website The Genderbread Person. Have...

As doctors have more ways to successfully treat cancer, they’ve also found that some cancer survivors are more likely than the general population to develop what is known as a...

Cancer is usually caused by a combination of many factors such as the environment, lifestyle, and other changes that happen to our genes over time. Sometimes, certain cancers may run...

Much as been made of the circadian system and its characteristic rhythms since the Nobel Prize was awarded to three different scientists in 2017 for their work in unraveling its...

Immunotherapy is one of the tools used in treating cancer, but it’s not known whether this treatment is safe and/or effective for those individuals who have both cancer and an...

Polycythemia vera is one of several types of blood cancer called myeloproliferative neoplasms, or MPN. The common factor in these diseases is that immature cells in the bone marrow (called...

Marginal zone lymphoma (MZL) is a slow-growing type of non-Hodgkin lymphoma (NHL), or blood cancer. Lymphocytes, a type of white blood cell in the immune system, has two types that...

Essential thrombocythemia is one of several types of blood cancer called “myeloproliferative neoplasms,” or MPN. The common factor in these diseases is that immature cells in the bone marrow (called...

What is a clinical trial? Does it impact the care of a cancer patient? These are the questions that puzzle many cancer patients. By participating in a clinical trial, a...

Trying to find a clinical trial for any type of blood cancer can sometimes feel overwhelming, but connecting to clinical trials is now easier than ever. Whether it’s your first...

Myelofibrosis is one of several types of blood cancer called “myeloproliferative neoplasms,” or MPN. The common factor in these diseases is that cells in the bone marrow that are supposed...

Research has played a powerful role in developing new understandings of how and why different cancers develop, which has led to breakthroughs in prevention, screening and diagnostic tools, and treatment...

There are three main types of blood cancers: lymphoma, leukemia, and myeloma.1 Roughly half of the blood cancers diagnosed each year are lymphomas. Lymphoma is a type of blood cancer...

Agent Orange is a chemical that was used during the 1960s and early 1970s as part of its war efforts in Vietnam, Laos and the Korean demilitarized zone. It was...